ヒト骨転移バイオマーカー臨床試験結果報告

津留 美智代; 永田 見生; 佐田 通夫; 松岡 啓; 山名 秀明; 田中 眞紀; 竹内 正弘; 角間 辰之; 前田 忠計; 山口 岳彦; 杉浦 英志

doi:10.14905/jscp.2007.0.5.0

The 3rd JSCP Conference

Session ID : 5

DOI https://doi.org/10.14905/jscp.2007.0.5.0

Conference information

Host: Japan Society for Clinical Proteomics

Oral Presentations

A prospective cohort study on bone metastasis biomarker.

*Michiyo Tsuru, Kensei Nagata, Michio Sata, Kei Matsuoka, Hideaki Yamana, Maki Tanaka, Masahiro Takeuchi, Tatsuyuki Kakuma, Tadakazu Maeda, Takehiko Yamaguchi, Hideshi Sugiura

Author information

*Michiyo Tsuru
Department of Orthopaedic Surgery, Kurume University School of Medicine.
Research Center for Innovative Cancer Therapy, Kurume University School of Medicine.
Research Center for Biostatistics, Kurume University School of Medicine.
Kensei Nagata
Department of Orthopaedic Surgery, Kurume University School of Medicine.
Research Center for Innovative Cancer Therapy, Kurume University School of Medicine.
Research Center for Biostatistics, Kurume University School of Medicine.
Michio Sata
Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine.
Research Center for Innovative Cancer Therapy, Kurume University School of Medicine.
Kei Matsuoka
Department of Urology, Kurume University School of Medicine.
Hideaki Yamana
Departments of Surgery, Kurume University School of Medicine.
Research Center for Innovative Cancer Therapy, Kurume University School of Medicine.
Maki Tanaka
Kurume Daiichi Social Insurance Hospital.
Masahiro Takeuchi
Division of Biostatistics, Kitasato University.
Research Center for Biostatistics, Kurume University School of Medicine.
Tatsuyuki Kakuma
Research Center for Biostatistics, Kurume University School of Medicine.
Tadakazu Maeda
Department of science physics, Kitasato University.
Takehiko Yamaguchi
Department of Clonical Pathology, Sapporo Medical University School of Medicine.
Hideshi Sugiura
Aichi Cancer Center.

Keywords: cancer, bone metastasis, biomarker, clinical test, proteomics

CONFERENCE PROCEEDINGS FREE ACCESS

Details

Abstract

This protein shows below important significance to become biomarker of bone metastasis. 1. Preparation of the patient to measure is serum. 2. Measurement time is short. 3. This protein recognized earlier than bone scintigraphy. This protein shows below important clinical significance to bone metastasis. 1. Prevention of bone metastasis is enabled. 2. We can make inhibitor of this protein. Expectation to pharmaceuticals for prevention of bone metastasis. 3. The pain of bone metastasis will be gone eternally. 4. Macrobiotic expectation of the cancer patients.

Corresponding author

Register with J-STAGE for free!